1. Home /
  2. Restructuring

Restructuring

These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis

No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.

A Look at Mylan's New Post-Merger Management

What new management means for Mylan shareholders moving forward.

Mylan Jumps on Deal With Pfizer to Form New Company

Pfizer will combine its off-patent drug business with Mylan in the as-yet-to-be-named new company.

Do Activists Have an Answer at Bed Bath & Beyond?

Is a turnaround even possible anymore?

Bed Bath & Beyond Continues Its Slide After Dismal Quarterly Report

Will BBBY be the next retailer to bite the dust?

Deutsche Bank Charts Look Like Those of a Company Fighting For Survival

There are no signs of accumulation of the beleaguered bank's shares and a sustainable base pattern is lacking.

Deutsche Bank Stock Declines as Transformation Plan Sinks In

Deutsche is looking to drop the "bad bank" moniker with big moves on Monday.

Caesars Soars as Traders Hail Eldorado Resorts Deal

The $17 billion acquisition of Caesars by Eldorado is welcomed by activist investor Carl Icahn, who had been pushing Caesars board for a deal.

Can Instagram Survive Independent From Facebook?

Is breaking up big tech just another big headache?

Teva Pharmaceuticals CEO: Stock on Track for 2020 Turnaround

But is a Teva turnaround still coming after the stock's 70% loss in the past five years?